[Protective effect of highly polymerized deoxyribonucleic acid against bone marrow aplasia following intense anti-cancer chemotherapy or radiocobalt irradiation].
D000741:Anemia, Aplastic / Q000188:drug therapy*; D001855:Bone Marrow Diseases / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D003036:Cobalt Isotopes / Q000627:therapeutic use; D004247:DNA / Q000627:therapeutic use*; D006801:Humans; D008579:Meningioma / Q000188:drug therapy / Q000532:radiotherapy; D008727:Methotrexate / Q000009:adverse effects*
D003036:Cobalt Isotopes; D004247:DNA; D008727:Methotrexate
Effet protecteur de l'acide désoxyribonucleique hautement polymérisé contre l'aplasie médullaire consécutive à la chimiothérapei anti-cancéreuse intense ou à l'irradiation au radiocobalt.